Total Payments
$19,227
2024 Payments
$3,500
Companies
51
Transactions
1,008
Medicare Patients
7,898
Medicare Billing
$633,765
Payment Breakdown by Category
Food & Beverage$18,430 (95.9%)
Education$446.54 (2.3%)
Consulting$350.00 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,430 | 968 | 95.9% |
| Education | $446.54 | 39 | 2.3% |
| Consulting Fee | $350.00 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,132 | 191 | $0 (2024) |
| Amgen Inc. | $1,336 | 67 | $0 (2024) |
| Lilly USA, LLC | $1,095 | 62 | $0 (2024) |
| Janssen Biotech, Inc. | $1,037 | 46 | $0 (2024) |
| PFIZER INC. | $926.84 | 52 | $0 (2024) |
| Celgene Corporation | $845.50 | 57 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $776.07 | 14 | $0 (2024) |
| Dermavant Sciences, Inc. | $772.02 | 64 | $0 (2024) |
| PruGen, Inc. Pharmaceuticals | $738.31 | 47 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $674.78 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,500 | 169 | ABBVIE INC. ($447.02) |
| 2023 | $3,442 | 160 | Arcutis Biotherapeutics, Inc. ($491.73) |
| 2022 | $2,449 | 111 | ABBVIE INC. ($500.16) |
| 2021 | $1,511 | 82 | AbbVie Inc. ($561.11) |
| 2020 | $1,356 | 62 | Journey Medical Corporation ($280.06) |
| 2019 | $2,903 | 155 | PruGen, Inc. Pharmaceuticals ($712.06) |
| 2018 | $1,758 | 141 | AbbVie, Inc. ($400.85) |
| 2017 | $2,310 | 128 | Promius Pharma LLC ($556.53) |
All Payment Transactions
1,008 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.17 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.06 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.82 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.98 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND, EBGLYSS | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Immunology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.07 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $33.51 | General |
| Category: Immunology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.70 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.64 | General |
| Category: Immunology | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.79 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.85 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $123.08 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,978 | 3,207 | $456,911 | $152,147 |
| 2022 | 19 | 1,945 | 5,148 | $458,612 | $154,716 |
| 2021 | 19 | 2,021 | 5,177 | $485,435 | $169,828 |
| 2020 | 21 | 1,954 | 4,743 | $500,043 | $157,075 |
Total Patients
7,898
Total Services
18,275
Medicare Billing
$633,765
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 475 | 609 | $97,136 | $36,423 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 331 | $77,951 | $29,242 | 37.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 268 | 326 | $63,929 | $20,731 | 32.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 288 | 383 | $55,497 | $13,868 | 25.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 118 | 140 | $34,678 | $10,361 | 29.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 15 | 16 | $14,998 | $5,418 | 36.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 82 | 122 | $12,912 | $4,715 | 36.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 195 | 965 | $11,194 | $4,683 | 41.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 31 | 35 | $13,493 | $4,472 | 33.1% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 37 | 43 | $13,605 | $3,838 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $11,197 | $3,613 | 32.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $11,352 | $3,394 | 29.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 25 | 27 | $14,737 | $3,209 | 21.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 58 | 65 | $6,221 | $2,547 | 40.9% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 12 | 12 | $6,264 | $2,303 | 36.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 21 | 22 | $5,423 | $1,797 | 33.1% |
| 69100 | Biopsy of ear | Office | 2023 | 17 | 19 | $4,193 | $921.00 | 22.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $2,132 | $613.03 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 476 | 589 | $93,946 | $36,541 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 233 | 301 | $70,886 | $25,637 | 36.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 240 | 286 | $56,085 | $18,980 | 33.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 316 | 403 | $58,395 | $15,690 | 26.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 112 | 140 | $34,678 | $9,575 | 27.6% |
| 95044 | Test for allergy using skin patch | Office | 2022 | 14 | 1,927 | $23,509 | $7,775 | 33.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 212 | 1,103 | $12,794 | $5,692 | 44.5% |
About Dr. Daniel Ring, MD
Dr. Daniel Ring, MD is a Dermatology healthcare provider based in Chesterfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790778249.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Ring, MD has received a total of $19,227 in payments from pharmaceutical and medical device companies, with $3,500 received in 2024. These payments were reported across 1,008 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($18,430).
As a Medicare-enrolled provider, Ring has provided services to 7,898 Medicare beneficiaries, totaling 18,275 services with total Medicare billing of $633,765. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Chesterfield, MO
- Active Since 08/30/2005
- Last Updated 04/03/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1790778249
Products in Payments
- Otezla (Drug) $1,787
- SKYRIZI (Biological) $1,335
- TALTZ (Drug) $1,053
- Humira (Biological) $1,020
- EUCRISA (Drug) $863.08
- VTAMA (Drug) $772.02
- TREMFYA (Drug) $729.32
- Sotyktu (Drug) $655.68
- OPZELURA (Drug) $617.49
- LIBTAYO (Biological) $559.35
- Cloderm Cream (Drug) $470.98
- RINVOQ (Biological) $449.46
- Bimzelx (Biological) $369.91
- DUPIXENT (Biological) $356.04
- DORYX (Drug) $355.77
- ENSTILAR (Drug) $349.35
- COSENTYX (Biological) $318.30
- SPEVIGO (Drug) $286.41
- TargaDox (Drug) $280.06
- HUMIRA (Biological) $252.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Chesterfield
Dr. Mark Kory, M.d, M.D
Dermatology — Payments: $212,129
Dermatology $212,129
Wayne Breer, Md, MD
Dermatology — Payments: $19,849
Dermatology $19,849
Lawrence Samuels, M.d, M.D
Dermatology — Payments: $18,199
Dermatology $18,199
Joseph Muccini, M.d, M.D
Dermatology — Payments: $17,150
Dermatology $17,150
Dr. Pooja Dorward, M.d, M.D
Dermatology — Payments: $10,002
Dermatology $10,002
Dr. James Donnelly, Md, MD
Dermatology — Payments: $3,254
Dermatology $3,254